In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor
about
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeysDifferential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in miceThe nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medicationsAntinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeysPharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Central N/OFQ-NOP Receptor System in Pain Modulation.Recently patented and promising ORL-1 ligands: where have we been and where are we going?UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice.Nociceptin modulates bronchoconstriction induced by sensory nerve activation in mouse lung.Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulata.Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic
P2860
Q24647780-AE47888B-9780-4983-80D9-07BF4705097DQ28246174-FB42AF00-B48F-465E-8095-E00D635AD7C2Q28297686-11BF415D-5449-4CF0-BC13-470586654D48Q33554807-9F1BBA9C-EBC3-4F62-B449-9FE8BEF6FA20Q33817107-607E4DA9-6967-4238-A865-54E0CEE2F28DQ34571432-CB44FB5C-6216-4B77-A16C-885FD4540E1DQ35026981-19B43893-5EF5-4F54-A054-2D2DDF11C839Q35738904-172BF509-797D-4204-9D54-25F490E2A854Q36603205-4B2F84CD-D72A-47C0-87C5-4445A3CB6152Q36638633-A676FB21-E160-403A-95AA-E21924C017B1Q36744366-BA0025A2-D401-43E2-9BE5-9516F9647266Q37094760-07FC0DA7-115E-4ADD-8EB7-03341F9CAFC6Q37697788-51673DE6-BC04-4769-B34B-68E5C9E68AC9Q37760247-A5E94854-7A23-43E4-A8D5-035F2C646533Q43484997-540E319B-B0D8-47EF-94BF-BF55A51CE126Q46008480-35CF412C-3F88-4186-9460-8423A2EA4B17Q47767855-D37B180A-0F55-4A16-89AD-1C8828A09F24Q49123582-7F306836-FF59-4A40-BDA8-8C4B7111A3FFQ58545262-579B4E64-8ED4-40E6-9453-65E012CE9AE3
P2860
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@ast
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@en
type
label
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@ast
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@en
prefLabel
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@ast
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@en
P2093
P2860
P50
P1433
P1476
In vitro and in vivo studies o ...... ociceptin/orphanin FQ receptor
@en
P2093
Anna Rizzi
Barbara Spagnolo
Carmela Fischetti
Daniel R Kapusta
Domenico Regoli
Girolamo Calo
Giuliano Marzola
P2860
P304
P356
10.1016/J.PEPTIDES.2007.04.020
P577
2007-05-06T00:00:00Z